2016: MY-osto-ME

An economical port, bag and belt system for urostomy patients that aims to reduce their rate of complications, facilitate application, and reduce social stigma; overall helping improve the quality of life of bladder cancer patients

 

PITCH PRESENTER: Dr. Nicholas Power, London Health Sciences Centre

 

2016: MY-osto-ME2016: MY-osto-ME


2015: ChemoTracker

A mobile health application that seeks to merge tracking of patients’ side effects and situations related to cancer treatments with patient-provider communication.

 

 

PITCH PRESENTER: Danielle Paes, FocusONCare

 

 

2015: ChemoTracker2015: ChemoTracker


2014: Ultra-Low Dose Microbubbles for Cancer

A new manufacturing process that creates microbubbles that are only responsive to the ultrasound frequency used in cancer treatment, enabling significantly lower volumes and costs while potentially improving safety.

 

PITCH PRESENTER: Dr. Naomi Matsuura, Sunnybrook Research Institute

 

2014: Ultra-Low Dose Microbubbles for Cancer2014: Ultra-Low Dose Microbubbles for Cancer


Fusion Pharmaceuticals Inc.

A clinical stage company focused on developing novel radiotherapeutics for the treatment of cancer. Fusion is a spin-out from the Centre for Probe Development and Commercialization (CPDC) at McMaster University, Hamilton.

Fusion Pharmaceuticals Inc.Fusion Pharmaceuticals Inc.


Novera Therapeutics Inc.

A biotherapeutics company focused on developing and commercializing therapies that improve patient outcomes in difficult-to-treat cancers. Their current focus is on the development of promising small molecule drug candidates for haematological cancers.

Novera Therapeutics Inc.Novera Therapeutics Inc.


Turnstone Biologics Inc.

Novel bio-therapeutics for the treatment of cancer: Turnstone Biologics extends the boundaries of the emerging field of cancer immunotherapy. Turnstone’s Maraba virus technology is a first-in-class tumour targeted oncolytic vaccine. Building on the recent clinical validation of OVs, the Maraba virus technology combines potent tumour killing effects with the benefits of a cancer vaccine, increasing anti-tumour immunity.

Turnstone Biologics Inc.Turnstone Biologics Inc.


Fluorinov Pharma Inc. (acquired by Trillium Therapeutics)

This novel, best-in-class orally bioavailable proteosome inhibitor is being developed for the treatment of multiple myeloma and other cancers.

Fluorinov Pharma Inc. (acquired by Trillium Therapeutics)Fluorinov Pharma Inc. (acquired by Trillium Therapeutics)


Privacy Analytics Inc.

This software platform, called Privacy Analytics Risk Assessment Tool (PARAT), unlocks the vast potential of data on diseases and patient care without compromising individual privacy.

Privacy Analytics Inc.Privacy Analytics Inc.


DVS Sciences Inc. (acquired by Fluidigm Sciences)

A unique analytical instrument for high throughput and highly multiplexed analyses of biomarkers for research, clinical trials and personalized medicine.

DVS Sciences Inc. (acquired by Fluidigm Sciences)DVS Sciences Inc. (acquired by Fluidigm Sciences)


Triphase Accelerator Corporation

An Accelerator enterprise formed to expedite proof-of-concept (PoC) and development of pre-IND cancer therapies, advancing in-licensed, clinically enabled oncology assets with high-value potential in a shared risk model for the purpose of out-licensing or selling the technology to create value. Triphase has formed a strategic partnership with Celgene Corporation to enable the rapid development of PoC in important new cancer therapies of mutual interest. 

Triphase Accelerator CorporationTriphase Accelerator Corporation


Cellax Nanoparticles for Enhanced Cancer Treatment

CellaxTM is a drug-polymer conjugate nanoparticle that when injected, selectively accumulates in tumours resulting in increased therapeutic benefits and reduced side effects.

Cellax Nanoparticles for Enhanced Cancer TreatmentCellax Nanoparticles for Enhanced Cancer Treatment


Xagenic Inc.

An inexpensive, sensitive, multiplex chip that detects DNA, RNA or protein targets directly without amplification steps. This project was to validate the GenEplex platform for clinical accepted biomarkers.

Xagenic Inc.Xagenic Inc.


XLV Diagnostics Inc.

This low cost system offers the potential for expanding women's access to digital mammography.

XLV Diagnostics Inc.XLV Diagnostics Inc.


Harmonic Medical Inc.

A system using ultrasound to both detect and treat tumours in bone and liver for the relief of pain without surgery and without expensive imaging equipment.

Harmonic Medical Inc.Harmonic Medical Inc.


Development of Radiolabeled Insulin Probe

A form of insulin labelled with technetium that is injected into the bloodstream and used to track changes in insulin metabolism, helping to find and monitor tumours.

Development of Radiolabeled Insulin ProbeDevelopment of Radiolabeled Insulin Probe


3D Ultrasound-Guided Prostate Biopsy and Therapy

A device and software that uses 3D ultrasound for highly accurate biopsy and treatment of prostate tumours even in large glands.

3D Ultrasound-Guided Prostate Biopsy and Therapy3D Ultrasound-Guided Prostate Biopsy and Therapy


CYP26 Inhibitors for Treatment of Acute Myeloid Leukemia

Development of novel CYP26 inhibitors for the treatment of leukemia and myeloma with potential greater specificity and less toxicity than current inhibitors.

CYP26 Inhibitors for Treatment of Acute Myeloid LeukemiaCYP26 Inhibitors for Treatment of Acute Myeloid Leukemia


MY-osto-ME Inc.

An economical port, bag and belt system for urostomy patients that aims to reduce their rate of complications, facilitate application, and reduce social stigma; overall helping to improve the quality of life of bladder cancer patients. 

MY-osto-ME Inc.MY-osto-ME Inc.


Heliotrope Bioinformatics Software Platform

A bioinformatics software platform that enables informed and actionable clinical decision by facilitating the interpretation and translation of tumor genomic sequencing data using comprehensive databases.

Heliotrope Bioinformatics Software PlatformHeliotrope Bioinformatics Software Platform


Development of the ChemoTracker Mobile Application

A mobile health application that seeks to merge tracking of patients’ side effects and situations related to cancer treatments with patient-provider communication.

Development of the ChemoTracker Mobile ApplicationDevelopment of the ChemoTracker Mobile Application


Ring Study to Evaluate the PRedicTive brEast Cancer Test (PRoTECT)

Evaluation of a Nanostring gene expression assay across three centres for its analytical reproducibility and accuracy in potentially guiding the selection of patient-specific therapies for early breast cancers.

Ring Study to Evaluate the PRedicTive brEast Cancer Test (PRoTECT)Ring Study to Evaluate the PRedicTive brEast Cancer Test (PRoTECT)


Ultra-Low Dose Microbubbles for Cancer Imaging

A proprietary method to manufacture, store and reconstitute monodisperse and size-tunable, lipid-based microbubbles for ultra-low dose, contrast-enhanced ultrasound.

Ultra-Low Dose Microbubbles for Cancer ImagingUltra-Low Dose Microbubbles for Cancer Imaging


A CEA Vaccine that Generates a Humoral Response to Break Tolerance

Evaluation of immune responses engendered in CEA transgenic mice by a vaccine formulation composed of a recombinant CEA N domain antigen and advanced adjuvant.

A CEA Vaccine that Generates a Humoral Response to Break ToleranceA CEA Vaccine that Generates a Humoral Response to Break Tolerance


Cell-Mate Technology for Esophageal Cell Sampling

Support for the use of Cell-Mate Technology in a clinical trial for the Genome Canada project entitled "Early detection of patients at high risk of esophageal adenocarcinoma".

Cell-Mate Technology for Esophageal Cell SamplingCell-Mate Technology for Esophageal Cell Sampling


External Clinical Validation Study of a Quantitative Ultrasound Spectral Analysis Platform

Use of clinical low frequency ultrasound for monitoring tumour response in women receiving neoadjuvant chemotherapy for locally advanced breast cancer.

External Clinical Validation Study of a Quantitative Ultrasound Spectral Analysis PlatformExternal Clinical Validation Study of a Quantitative Ultrasound Spectral Analysis Platform